Skip to main content

Table 5 Vital signs (means ± standard deviation) in the ITT population.

From: Safety and effects of two mistletoe preparations on production of Interleukin-6 and other immune parameters - a placebo controlled clinical trial in healthy subjects

  Group Baseline Exposure Exposure Exposure Follow-up
    Week 4 Week 8 Week 12 Week 16
Body temperature IP 36.4 ± 0.4 36.4 ± 0.4 36.3 ± 0.5 36.4 ± 0.4 36.5 ± 0.3
  VM 36.5 ± 0.4 36.2 ± 0.5 36.3 ± 0.5 36.3 ± 0.3 36.4 ± 0.3
  PL 36.3 ± 0.4 36.3 ± 0.3 36.4 ± 0.4 36.4 ± 0.3 36.5 ± 0.4
Systolic blood pressure IP 120 ± 11 117 ± 11 114 ± 10 117 ± 11 112 ± 12
  VM 112 ± 10 114 ± 10 110 ± 11 111 ± 12 112 ± 13
  PL 112 ± 13 110 ± 11 113 ± 9 111 ± 13 112 ± 13
Heart rate IP 76 ± 11 72 ± 7 74 ± 9 71 ± 9 72 ± 11
  VM 71 ± 9 74 ± 11 70 ± 8 68 ± 8 66 ± 9
  PL 74 ± 8 71 ± 9 72 ± 6 72 ± 9 74 ± 7
  1. IP = Iscucin® Populi, VM = Viscum Mali e planta tota, PL = placebo.